Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Landscape of Microsatellite Instability Across 39 Cancer Types
Russell Bonneville, Melanie A. Krook, Esko A. Kautto, et al.
JCO Precision Oncology (2017), Iss. 1, pp. 1-15
Open Access | Times Cited: 1276

Showing 1-25 of 1276 citing articles:

Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study
Aurélien Marabelle, Dung T. Le, Paolo A. Ascierto, et al.
Journal of Clinical Oncology (2019) Vol. 38, Iss. 1, pp. 1-10
Open Access | Times Cited: 2374
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
Jakob Nikolas Kather, Alexander T. Pearson, Niels Halama, et al.
Nature Medicine (2019) Vol. 25, Iss. 7, pp. 1054-1056
Open Access | Times Cited: 1055
Conserved pan-cancer microenvironment subtypes predict response to immunotherapy
Alexander Bagaev, Nikita Kotlov, Krystle Nomie, et al.
Cancer Cell (2021) Vol. 39, Iss. 6, pp. 845-865.e7
Open Access | Times Cited: 813
The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker
Denis L. Jardim, Aaron M. Goodman, Débora De Melo Gagliato, et al.
Cancer Cell (2020) Vol. 39, Iss. 2, pp. 154-173
Open Access | Times Cited: 808
Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy
Pengfei Zhao, Li Li, Xiaoyue Jiang, et al.
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 530
DNA mismatch repair in cancer
Marina Baretti, Dung T. Le
Pharmacology & Therapeutics (2018) Vol. 189, pp. 45-62
Closed Access | Times Cited: 463
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer
Mansoor Raza Mirza, Dana M. Chase, Brian M. Slomovitz, et al.
New England Journal of Medicine (2023) Vol. 388, Iss. 23, pp. 2145-2158
Open Access | Times Cited: 459
A rectal cancer organoid platform to study individual responses to chemoradiation
Karuna Ganesh, Chao Wu, Kevin P. O’Rourke, et al.
Nature Medicine (2019) Vol. 25, Iss. 10, pp. 1607-1614
Open Access | Times Cited: 425
Microsatellite instability: a review of what the oncologist should know
Kai Li, Haiqing Luo, Lianfang Huang, et al.
Cancer Cell International (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 399
Triple‑negative breast cancer therapy: Current and future perspectives (Review)
Kwang‐Ai Won, Charles Spruck
International Journal of Oncology (2020) Vol. 57, Iss. 6, pp. 1245-1261
Open Access | Times Cited: 352
Pembrolizumab in Patients With Microsatellite Instability–High Advanced Endometrial Cancer: Results From the KEYNOTE-158 Study
David M. O’Malley, Giovanni M. Bariani, Philippe A. Cassier, et al.
Journal of Clinical Oncology (2022) Vol. 40, Iss. 7, pp. 752-761
Open Access | Times Cited: 340
Implementing TMB measurement in clinical practice: considerations on assay requirements
Reinhard Büttner, John Longshore, Fernando López‐Ríos, et al.
ESMO Open (2019) Vol. 4, Iss. 1, pp. e000442-e000442
Open Access | Times Cited: 323
Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer
Vicky Makker, Nicoletta Colombo, Antonio Casado, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 5, pp. 437-448
Open Access | Times Cited: 323
Recent advances in triple negative breast cancer: the immunotherapy era
Antonio Marra, Giulia Viale, Giuseppe Curigliano
BMC Medicine (2019) Vol. 17, Iss. 1
Open Access | Times Cited: 319
Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer
Anqi Lin, Jian Zhang, Peng Luo
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 275
Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer
Jiao Hu, Anze Yu, Belaydi Othmane, et al.
Theranostics (2021) Vol. 11, Iss. 7, pp. 3089-3108
Open Access | Times Cited: 273
Pembrolizumab in microsatellite instability high or mismatch repair deficient cancers: updated analysis from the phase II KEYNOTE-158 study
Michele Maio, Paolo A. Ascierto, L. V. Manzyuk, et al.
Annals of Oncology (2022) Vol. 33, Iss. 9, pp. 929-938
Open Access | Times Cited: 272
The Current Landscape of Immune Checkpoint Blockade in Hepatocellular Carcinoma
Matthias Pinter, Rakesh K. Jain, Dan G. Duda
JAMA Oncology (2020) Vol. 7, Iss. 1, pp. 113-113
Open Access | Times Cited: 259
The current state of molecular testing in the treatment of patients with solid tumors, 2019
Wafik S. El‐Deiry, Richard M. Goldberg, Heinz‐Josef Lenz, et al.
CA A Cancer Journal for Clinicians (2019) Vol. 69, Iss. 4, pp. 305-343
Open Access | Times Cited: 233
Tumor immune microenvironment and immune checkpoint inhibitors in esophageal squamous cell carcinoma
Yoshifumi Baba, Daichi Nomoto, Kazuo Okadome, et al.
Cancer Science (2020) Vol. 111, Iss. 9, pp. 3132-3141
Open Access | Times Cited: 208
Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups
Matthias Pinter, Bernhard Scheiner, Markus Peck‐Radosavljevic
Gut (2020) Vol. 70, Iss. 1, pp. 204-214
Open Access | Times Cited: 199
Mismatch Repair Pathway, Genome Stability and Cancer
Nives Pećina‐Šlaus, Anja Kafka, Iva Salamon, et al.
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 196
BRAF Mutant Lung Cancer: Programmed Death Ligand 1 Expression, Tumor Mutational Burden, Microsatellite Instability Status, and Response to Immune Check-Point Inhibitors
Elizabeth Dudnik, Nir Peled, Hovav Nechushtan, et al.
Journal of Thoracic Oncology (2018) Vol. 13, Iss. 8, pp. 1128-1137
Open Access | Times Cited: 190
Validation of Microsatellite Instability Detection Using a Comprehensive Plasma-Based Genotyping Panel
Jason Willis, Martina I. Lefterova, Alexander Artyomenko, et al.
Clinical Cancer Research (2019) Vol. 25, Iss. 23, pp. 7035-7045
Open Access | Times Cited: 187
A Novel Next-Generation Sequencing Approach to Detecting Microsatellite Instability and Pan-Tumor Characterization of 1000 Microsatellite Instability–High Cases in 67,000 Patient Samples
Sally E. Trabucco, Kyle Gowen, Sophia L. Maund, et al.
Journal of Molecular Diagnostics (2019) Vol. 21, Iss. 6, pp. 1053-1066
Open Access | Times Cited: 186
Page 1 - Next Page

Scroll to top